PEPTIDA S.R.L. SELECTED AS FINALIST IN WIPO’S GLOBAL AWARDS, STANDING OUT AMONG 780 GLOBAL INNOVATORS

Chosen from nearly 800 applicants across 95 countries, PepTiDa earns global recognition for its innovative use of intellectual property

Redazione- PepTiDa, a pioneering Italian company in the health care sector has been selected as one of the 30 global finalists in the 2025 WIPO Global Awards, organized by the World Intellectual Property Organization (WIPO).

The WIPO Global Awards celebrate the achievements of startups and small and medium-sized enterprises (SMEs) that have successfully used intellectual property (IP) assets to fuel business growth and societal impact. This year’s edition attracted a record 780 fully submitted applications from 95 countries, 30 finalists were shortlisted by the WIPO Secretariat.

"Being selected as a finalist for the WIPO Global Awards is a significant honor for our team,” said Prof. Tiziana Borsello, Founder & CEO of PepTiDa. “It validates our efforts to build a business rooted in innovation, backed by a thoughtful IP strategy. We are proud to be recognized on a global stage and to represent Italy in this inspiring group of innovators.”

Finalists were assessed on the suitability of their business model and IP portfolio, their international IP strategy, their internal IP culture, and their positive impact on society. PepTiDa's inventive approach in Life Science and IP strategy has enabled the development of neuroprotectant to address Brain diseases.

“The finalists for the WIPO Global Awards exemplify the power of IP in action,” said Mr. Marcelo Di Pietro, Director, WIPO Awards Program. “These companies show how creativity and IP rights can be combined to generate tangible benefits – for their businesses and for the world. We warmly congratulate PepTiDa for reaching this stage.”

The winners among the finalists will be announced at the official WIPO Global Awards Ceremony on the 11^th of July 2025, held during the 66th WIPO General Assembly in Geneva, Switzerland.

About PepTiDa is an INNOVATIVE STARTUP born in June 2024, SPIN-OFF from University of Milan, BIOTECH/PHARMA company. Our VISION: Revolutionizing neuroprotection with an innovative peptide, improving the quality of life for people affected by brain diseases (AD, stroke, etc.)

About the WIPO Global Awards

The WIPO Global Awards honor startups and small and medium-sized enterprises (SMEs) that use intellectual property (IP) as a driver for innovation, business growth, and positive social impact. The program is organized by the World Intellectual Property Organization (WIPO), a specialized agency of the United Nations, and is part of its broader mission to foster innovation and creativity for the benefit of all.

For more information about PepTiDa please email us at Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo., Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo. and for more information about the WIPO Global Awards, please email us at Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo..

Marialuisa Roscino, Scientific Journalist, specialized in Health issues and in particular in Nutrition Education and Eating Disorders. Among her previous and multiple professional experiences as a journalist in the medical-scientific field, in addition to the care of important scientific Congresses for the Media & Press section, significant: the press office and communication activity at the Press Office and the Communication and External Relations Service at the Bambino Gesù Pediatric Hospital in Rome and at the Italian Red Cross as National Coordinator for Visibility and Communication Activities